News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson (JNJ)     9/21/2017
Alnylam (ALNY) Stock Catapults as Genetic Disease Drug Meets All Phase III Goals     9/20/2017
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials     9/20/2017
Eli Lilly (LLY) Heads to Finish Line with Breast Cancer Treatment Abemaciclib     9/20/2017
Nabriva (NBRV)'s Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials     9/19/2017
Bill & Melinda Gates Foundation Sinks $40 Million Into Immunocore for Infectious Disease R&D     9/19/2017
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller     9/18/2017
Show Me The Money: Bay Area’s Top 5 Venture Capital-Backed Biotechs     9/18/2017
This Regeneron (REGN) Drug Just Took Another Step Toward Blockbuster Status     9/15/2017
Bavarian Nordic (BAVA.CO) Plummets 49% After Cancer Vaccine Flunks Late-Stage Test     9/15/2017
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data     9/15/2017
FDA Calls Regeneron (REGN), Sanofi (SNY) Carcinoma Drug a Breakthrough     9/15/2017
Amicus (FOLD) Dumps Lead Rare Disease Drug After Phase III Trial Failure     9/14/2017
SAGE Therapeutics (SAGE) Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test     9/13/2017
Vertex (VRTX)’s Terminated Phase II CF Trial Was Planned     9/13/2017

News from Around the Web
How Will Artificial Intelligence Impact Alzheimer’s Research?     9/21/2017
UK Warns About Alarm Failure for Roche (RHHBY)’s Accu-Check Insight Insulin Pumps     9/21/2017
People With Schizophrenia Have Threefold Risk Of Dying, Canadian Medical Association Journal Reveals     9/20/2017
No More 'Bad Fat'? A Potential Weight-Loss Treatment Could Make Fat Burn Itself, Washington University in St. Louis Study Reveals     9/20/2017
New Assay Leads To Step Toward Gene Therapy For Deaf Patients, Oregon State University Study     9/20/2017
Fluorescence Microscopy On A Chip: No Lenses Required, American Institute of Physics Reveals     9/20/2017
New Bionic-Eye Brain Implants Could Help More Blind People Than A Device Already On The Market     9/20/2017
Will You Lose Weight? Take A Look At Your Poop, University of Copenhagen Study Reveals     9/19/2017
Down But Not Out: Juno (JUNO) Preps For Second Round Of CAR-T Cancer War     9/18/2017
Love Handles Get Dissolved By New Skin Patch, University of North Carolina Study Reveals     9/18/2017
IBM (IBM) Pitched Its Watson Supercomputer As A Revolution In Cancer Care. It’s Nowhere Close     9/18/2017
New Flexible, Organic Battery Could Revolutionize Medical Implants, Queen’s University Study Reveals     9/18/2017
How BIOHM's At Home Candida Test Is Giving Consumers Peace of Mind     9/18/2017
Vitamin D Levels May Help Predict Risk Of MS, Neurology Reveals     9/15/2017
How Seaweed Could Prove To Be The Secret To Healing Brain Tissue Damaged By Stroke Or Trauma, RMIT University Study     9/15/2017

Press Releases
Theravance Biopharma (TBPH) Highlights Positive Headline Results From IMPACT Study Of Trelegy Ellipta Announced By GlaxoSmithKline (GSK) And Innoviva Inc. (THRX)     9/21/2017
Arbutus Biopharma (ABUS)’ LNP Licensee Alnylam (ALNY) Announces Positive Phase III Results For LNP-Enabled Patisiran Program     9/21/2017
Akari to Push Lead Drug Into Phase III For PNH In Q1 2018, Stock Surges     9/21/2017
Biocryst (BCRX)’s RAPIVAB (peramivir injection) Receives FDA Approval For A Pediatric Indication     9/21/2017
AstraZeneca Canada (AZN) Release: First-In-Class BRCA-Positive Ovarian Cancer Medicine Lynparza (Olaparib) Receives Positive Pan-Canadian Oncology Drug Review (pCODR) Recommendation For Provincial Reimbursement     9/21/2017
Perrigo (PRGO) Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo 32mg Extended Release Tablets     9/21/2017
Paratek (PRTK) Release: Omadacycline Receives Qualified Infectious Disease Product Designation From FDA For An Additional Indication In Uncomplicated Urinary Tract Infection     9/21/2017
Bavarian Nordic (BAVA.CO) Provides Update On Its Universal RSV Vaccine     9/21/2017
Sanofi (SNY) And NIH Researchers Develop "Three-In-One" Antibodies As A Potential Breakthrough Intervention For HIV/AIDS     9/21/2017
Amicus (FOLD) Release: FDA Grants Orphan Drug Designation For ATB200/AT2221 For Pompe Disease     9/21/2017
FLX Bio Selects Immuno-Oncology Clinical Candidate     9/21/2017
ProQR Therapeutics (PRQR) Presents In Vivo Proof Of Concept Data For The Axiomer RNA Editing Platform Technology     9/21/2017
Inovio Pharma (INO) dMAB Constructs Shrink Prostate Tumors And Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies     9/21/2017
Orthopaedic Research Society Release: Microbiome Manipulation Decelerates Osteoarthritis Progression     9/21/2017
Millennium Health Release: New Study Finds Heroin-Positive Patients Have Increasing Co-Occurrence Of Non-Prescribed Fentanyl     9/21/2017